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a b s t r a c t
The A3243G mutation is one of the most frequent mutations of mitochondrial DNA. The
phenotypic expression of the A3243G mutation is variable and causes a wide range of
syndromic and non-syndromic clinical disorders. Mitochondrial myopathy, encephalopa-
thy, lactic acidosis and stroke-like episodes (MELAS) syndrome is the most frequent syn-
dromic manifestation of the A3243G mutation. Stroke-like episodes seem to be the dominant
feature of MELAS. We have investigated the case of a family with A3243G mutation, in which
a dominant symptom in three generations was the maternally inherited hearing loss with
absence of stroke-like episodes. Besides deafness, we found also other clinical features such
as myopathy, neuropathy, migraine, ataxia, short stature, diabetes mellitus, and cardiomy-
opathy.
# 2014 Polish Neurological Society. Published by Elsevier Urban & Partner Sp. z o.o. All
rights reserved.
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The maternally inherited point mutation of A3243G in the
mtDNA is the most frequent cause of mitochondrial multisys-
tem disorder with a variable clinical phenotype [1]. The
prevalence of A3243G mtDNA was estimated to be 0.95–16.3
per 100,000 – much higher than previously reported [2,3]. In 80%
of cases, mtDNA A3243G mutation is associated with a
mitochondrial encephalomyopathy, lactic acidosis and
stroke-like episodes (MELAS). The same mutation may cause
clinically well-deﬁned combinations of symptoms such as* Corresponding author at: Zakład Neurochemii i Neuropatologii, UM im
Poznań, Poland.
E-mail address: adamszczucinski@poczta.onet.pl (A. Szczuciński).
0028-3843/$ – see front matter # 2014 Polish Neurological Society. Pu
http://dx.doi.org/10.1016/j.pjnns.2013.12.007maternally inherited diabetes and deafness (MIDD), myoclonus
epilepsy with ragged red ﬁbres (MERRF), progressive external
ophthalmoplegia (PEO) and Leigh syndrome (LS) [4,5]. However,
the phenotype of many A3243G mutants does not comply with
any of these syndromes (non-syndromic manifestations).
2. Case presentation
A 48-year-old woman (Fig. 1IVA) was admitted to our clinic for
progressive hearing loss, generalized muscle weakness and gait
difﬁculties. She had a history of normal birth and development.. K. Marcinkowskiego w Poznaniu, ul. Przybyszewskiego 49, 60-355
blished by Elsevier Urban & Partner Sp. z o.o. All rights reserved.
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Fig. 1 – The pedigree of family with A3243G mutation. The
proportion of mutant mtDNA in hair follicles (H), nail (N),
urinary sediment (U) and peripheral blood leukocytes (L).
Table 1 – Patient's laboratory test results.
Lab tests Normal range
White blood cell count 11.2  103/mL 3.9–11.0
Red blood cell count 7  106/mL 3.5–5.2
Hematocrit 52.6% 33.0–46.0
Haemoglobin 18.9 g/dL 12.0–15.6
Mean corpuscular volume 78.9 fL 88.0–99.0
Platelet count 477  103/mL 120–400
Glucose (fasting) 155 mmol/L 60–99
Glycosylated
haemoglobin (HbA1c)
9.2% 4.0–5.6
Sodium 128 mmol/L 136–145
Potassium 5.3 mmol/L 3.5–5.1
Calcium 9.3 mg/dL 8.8–10.2
Phosphorus 4.5 mg/dL 2.7–4.5
Calcium 9.3 mg/dL 8.8–10.2
Phosphorus 4.5 mg/dL 2.7–4.5
Urea 31 mg/dL 17–50
Creatinine 0.6 mg/dL 0.5–0.9
Creatine kinase 67 U/L 26–140
Serum lactate 3.0 mmol/L 0.5–2.2
Cerebrospinal ﬂuid lactate 4.7 mmol/L 1.2–2.4
Aspartate transaminase 21 U/L 10–31
TSH 0.6 mIU/mL 0.28–4.6
Cortisol at 09:00 am 594 nmol/L 171–536
Adrenocorticotropic hormone 17.7 pg/mL <60
Aldosterone 96 pg/mL 10–160
Plasma renin activity <0.15 ng/mL/h 0.5–1.9
Capillary blood gasometry
pH 7.4 7.35–7.45
PvCO2 26.9 mm Hg 32–45
PvO2 94.8 mm Hg 75–100
HCO3 16.2 mmol/L 21–27
SO2 94.7% 95–95%
Fig. 2 – Brain magnetic resonance image scan showing
ischaemic lesions in the parietal regions.
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workingasanofﬁceworker.Shehadbeenhealthyuntil theageof
33 when she developed bilateral hypoacusis. One year later she
was diagnosed with diabetes and started insulin therapy. Until
the age of 45, she had a slow progression of hearing impairment.
Since then, she has experienced a rapidly progressing deafness.
She was assessed for a cochlear implant. Besides the hearing
loss, she also noticed weakness of the lower extremities,
fatigability, and imbalance. One year before admission, she
had been diagnosed as having hypertrophic cardiomyopathy
and polycythemia vera. She had not suffered from stroke-like
episodes, seizures, dementia or recurring headache.
Physical examination revealed her to be emaciated, with a
weight of 46 kg and a height of 165 cm; body mass index was
17. Her pulse was 62 beats/min and blood pressure 118/
62 mm Hg. Fundoscopic examination revealed no diabetic
retinopathy. Visual acuity was normal in both eyes. Examina-
tion of the cranial nerves showed bilateral severe deafness.
She had generalized muscle weakness and atrophy, but more
severe in the proximal limb muscles. The deep tendon reﬂexes
were decreased. Her gait was broad-based, and she was unable
to walk a straight line. The coordination was impaired by mild
ataxia and dysdiadochokinesia. The Romberg test was posi-
tive. Her sensory examination was normal.
Results of routine laboratory tests on admission are shown
in Table 1. An audiogram showed profound (>100 dB)
sensorineural hearing loss on her left and severe (75 dB)
deﬁcit on right ear. Echocardiography indicated left ventricular
hypertrophy with moderate mitral regurgitation and left
ventricular systolic dysfunction with decreased ejection
fraction (35–40%). Twenty-four-hour ECG showed no cardiac
rhythm disorder. Electromyography and nerve conduction
studies revealed a length-dependent sensorimotor axonal
polyneuropathy. Magnetic resonance imaging (MRI) demon-
strated mild vermis atrophy, notable cortical atrophy, and
subcortical lesions of increased signal intensity in the parietal
regions (Fig. 2). Magnetic resonance angiography was normal.
Table 2 – Family with A3243G mutation.
IB IIB IIIC IVA IVC VA VB
Age of onset (years) ? ? 57 33 31 4 4
Hearing loss + + + + + + +
Short stature     + + +
Neuropathy   + +   
Muscle weakness   + +   
Ataxia   + +   
Migraine     +  
Stroke       
Seizure       
Lactic acidosis    +   
Diabetes    +   
Cardiomyopathy    +   
Polycythemia vera    +   
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and the A3243G mutation was identiﬁed by polymerase chain
reaction (PCR). The heteroplasmy rates were 12.7%, 32.4% and
31.4%, respectively. She declined to undergo a muscle biopsy.
A detailed clinical examination was carried out on the
mother of our patient (Fig. 1IIIC). The 72-year-old woman
presented with a 4-year history of progressive weakness in her
right upper extremity and both lower extremities resulting in
frequent falls and difﬁculty standing from a chair, climbing
stairs and carrying objects. Additionally, she complained of
dysarthria and dizziness, as well as gait disturbance. Since the
age 57, she has been suffering from progressive hearing
impairment. She was underweight with a weight of 44 kg and a
height of 166 cm.
On examination, she was intellectually normal, but she had
moderate dysarthria. The cranial nerve examination was
normal except for bilateral sensorineuronal hearing loss. The
physical examination demonstrated atrophy and wasting of
the proximal limb muscles. The neurologic examination
revealed signiﬁcant muscle weakness in the four extremities
and muscle hypotonia. The deep tendon reﬂexes were
decreased in both legs and arms. Her gait was wide-based
with marked ataxia. The sensory examination was normal. A
Romberg sign was present. Her Mini-Mental Status Examina-
tion (MMSE) score was normal (28/30 points).
Her extensive laboratory studies were normal, including a
normal blood glucose and a normal glycosylated haemoglobin
level. The concentration of lactate in blood was normal. Brain
MRI revealed notable cortical atrophy, ventricular dilatation
and cortical hyperintensity of the frontal and parietal lobes
with restricted diffusion.
Electromyography and nerve conduction study conﬁrmed a
length-dependent sensory axonal polyneuropathy. The mito-
chondrial DNA A3243G point mutation was detected in both
hair follicles and nail, and the degree of mutated DNA was
14.8% and 2.3%, respectively.
A 43-year-old sister of our patient (IVC) had been suffering
migraine headache for 12 years. She and her two daughters –
10-year old (Fig. 1VA) and 5-year old (Fig. 1VB) – had short
stature and mild bilateral hypoacusis. They carried the
mitochondrial A3243G mutation and had previously been
diagnosed as having MELAS syndrome. They had no history of
stroke-like episodes (brain MRI scans revealed no focalabnormality) or lactic acidosis and had no other symptoms.
We did not have opportunity to examine them.
The maternal grandmother (Fig. 1IIB) and the maternal
great-grandmother (Fig. 1IB) both had bilateral deafness as the
only symptom. However, they had never been admitted for
any detailed examination. Various symptoms and diseases
that have been found in members of the family with A3243G
mutation are presented in Table 2.
3. Discussion
We have investigated the case of one family with A3243G
mutation, in which a dominant symptom in four generations
was the maternally inherited sensorineural hearing loss. The
clinical picture of our 48-year-old patient typically ﬁts that
observed in patients with the maternally inherited diabetes
and deafness (MIDD) syndrome. However, it is not an
appropriate acronym for our case due to the absence of
diabetes and the presence of variable other symptoms in the
maternal family members. Our patient had clinical, neurora-
diological and metabolic features of mitochondrial encepha-
lomyopathy (ataxia, severe deafness, generalized muscle
weakness and atrophy, cardiomyopathy, brain and cerebellar
atrophy, diffuse white-matter lesions, lactate increase in
cerebrospinal ﬂuid). Additionally, she was diagnosed with
polycythemia vera – this association with mtDNA A3243G
mutation has not been reported in the literature. To our
knowledge, however, mitochondrial disorders predominantly
manifest in tissues with high-energy requirements, such as
the central nervous system, peripheral nervous system, heart,
muscle, endocrine glands, kidneys, eyes, inner ears and also
bone marrow [6]. The mutation causes respiratory chain
deﬁciency with impaired oxidative phosporylation and ATP
production [2].
Regarding the family history, the mother (Fig. 1IIIC) of our
patient had clinical features of muscle weakness, peripheral
sensory neuropathy, cerebellar ataxia and hearing loss which
occurred in the ﬁfth decade. The younger sister (Fig. 1IVC) of
our patient and her two daughters had mild hypoacusis and
short stature and also had the A3243G point mutation. They
had previously been diagnosed with MELAS syndrome. The
characteristic clinical features of MELAS syndrome are
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stroke-like episodes at young age (usually < 40 years), lactic
acidosis and myopathy with ragged-red ﬁbres [7,8]. However,
none of the family members have ever experienced any of the
typical clinical features of MELAS. Their condition should be
classiﬁed as non-syndromic mitochondrial disorder. MELAS
is the commonest of the mitochondrial disorders but the
mitochondrial A3243G mutation does not necessarily imply
MELAS. Other frequent clinical manifestations of A3243G
mutation include: sensorineural deafness, progressive exter-
nal ophthalmoplegia, dementia, ataxia, diabetes, pigmentary
retinopathy, myoclonic, hypoparathyroidism, peripheral
neuropathy and cardiomyopathy in various combinations
[4,9,10].
The phenotypic heterogeneity observed in investigated
family may be the consequence of variable percentage of
mutation load (cellular content of the A3243G mutation)
among various tissues – a phenomenon called heteroplasmy
[11]. Level of heteroplasmy is usually higher in muscles (up to
92%), but mutation may be also detected in hair follicles, blood
lymphocytes or urinary sediments [10]. Several studies have
shown that levels of heteroplasmy for the A3243G mutation
decrease with age in most tissues [12]. On the contrary, a high
degree of heteroplasmy is associated with an earlier age of
onset of the disease and severity of the phenotype [10,13,14].
The varied clinical expression of mtDNA mutation in one
family often makes appropriate diagnosis a considerable
challenge.
In conclusion, we reported the case of a family with A3243G
mtDNA mutation with a dominant symptom of maternally
inherited sensorineural hearing loss. A3243G mtDNA muta-
tion should be considered as a potential cause of various
neurological disorders even in patients without any classic
clinical features of MELAS syndrome.
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